Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion;Zasady dawkowania insuliny w terapii z zastosowaniem osobistej pompy insulinowej u dzieci i młodzieży choruja̧cych na cukrzycȩ typu 1

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 12, Issue 1, 2006, Pages 45-50

  Szypowska, Agnieszka ^a,b   Pańkowska, Ewa ^a   Lipka, Maria ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Szpital Kliniczny AM   (Poland)

Author keywords

Children; Continuous subcutaneous insulin infusion; Diabetes mellitus type 1; Insulin pump; Intensive insulin therapy

Indexed keywords

CARBOHYDRATE; FAT; GLUCOSE; INSULIN; PROTEIN;

DIET; DRUG DOSE REGIMEN; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KETOACIDOSIS; METABOLIC REGULATION; REVIEW;

CHILD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; PRACTICE GUIDELINES;

EID: 33645963174     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. The Diabetes Control and Complication Trial Research Group: Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J. Pediatr., 2001, 139, 804.
2. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 1993, 329, 877.
3. Bulsara M.K., Holman C.D., Davis E.A., Jones T.W.: The impact of decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care, 2004, 27, 2293.
4. Pańkowska E., Lipka M., Wysocka M. i wsp.: Wyrównanie metaboliczne u małych dzieci z cukrzyca̧ typu 1 leczonych metoda̧ cia̧głego podskórnego wlewu insuliny (pompy insulinowe). Endokrynol. Diabetol. Chor. Przemiany Materii Wieku Rozw., 2003, 9, 11.
5. Pańkowska E., Lipka M., Szypowska A.: Insulinoterapia i osobiste pompy insulinowe w praktyce pediatrycznej. Przegl. Pediatr., 2003, 33, 158.
6. Weinzimer S.A., Doyle E.A., Steffen A.T. i wsp.: Rediscovery of insulin pump treatment of childhood type 1 diabetes. Minerva Med., 2004, 95, 85.
7. Willi S.M., Planton J., Egede L., Schwarz S.: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J. Pediatr., 2003, 143, 796.
8. Wilson D.M., Buckingham B.A., Kunselman E.L. i wsp.: A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care, 2005, 28, 15.
9. Bittner C., Lüpke K., Schütz W., Danne T.: Which children and adolescents with type 1 diabetes profit from insulin pump therapy? J. Pediatr. Endocrinol. Metab., 2003, 16, supl. 4, 925.
10. Fox L.A., Buckloh L.M., Smith S.D. i wsp.: A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care, 2005, 28, 1277.
11. Heidtmann B., Lang E., Klinkert C. i wsp.: Insulin pump therapy in pediatric patient with type 1 diabetes: Multicenter analysis based on the DPU-Science initiative. J. Pediatr. Endocrinol. Metab., 2002, 15, supl. 4, 1079.
12. Minkina-Pedras M., Jarosz-Chobot P., Deja G. i wsp.: Twelve-month assesment of therapy with CSII in children with type 1 diabetes. J. Pediatr. Endocrinol. Metab., 2003, 16, supl. 4, 936.
13. Polak M., Shield J.: Neonatal and very-early-onset diabetes mellitus. Semin. Neonatol., 2004, 9, 59.
14. Rami B., Nachbaur E., Schober E.: Continuous subcutaneous insulin infusion in young children. J. Pediatr. Endocrinol. Metab., 2002, 15, supl. 4, 1086.
15. Shehadeh N., Battelino T., Galalzer A. i wsp.: Insulin pump therapy for 1-6 year old children with type 1 diabetes. Isr. Med. Assoc. J., 2004, 6, 284.
16. Keith K., Nicholson D., Rogers D.: Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin. Pediatr. (Phila), 2004, 43, 69.
17. Sullivan-Bolyai S., Knafl K., Tamborlane W., Grey M.: Parents reflections on managing their children's diabetes with insulin pumps. J. Nurs. Scholarsh., 2004, 36, 316.
18. Tamborlane W.V., Fredrickson L.P., Ahern J.H.: Insulin pump therapy in childhood diabetes mellitus: guidelines for use. Treat. Endocrinol., 2003, 2, 11.
19. Urban M.D., Longo S., Evans T., Stolfi A.: Insulin pump therapy improves diabetic control and quality of life in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2002, 15, supl. 4, 1092.
20. Weinzimer S., Ahren J., Boland E. i wsp.: CSII is safe and effective in very young children with type 1 diabetes. Diabetes, 2003, 52, supl. 1, 1744.
21. Weinzimer S.A., Ahern J.H., Doyle E.A. i wsp.: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics, 2004, 114, 1601.
22. Tatoń J., Czech A.: Diabetologia. PZWL, Warszawa, 2001, 273.
23. Melki V., Renard E., Lassmann-Vague V. i wsp.: Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care, 1998, 21, 977.
24. Renner R., Pfutzner A., Trautmann M. i wsp.: Use of insulin lispro in continuous subcutaneous insulin treatment: results of a multicenter trial. Diabetes Care, 1999, 22, 784.
25. Zinman B.: Insulin pump therapy and rapid acting insulin: what have we learned? Int. J. Clin. Pract., 2001, 123, 47.
26. Zinman B., Tildesley H., Chiasson J.L. i wsp.: Insulin lispro in CSII results of a double-blind crossover study. Diabetes, 1997, 46, 440.
27. Radermecker R.P., Scheen A.J.: Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes. Metab. Res. Rev., 2004, 20, 178.
28. Schiel R.: Continuous subcutaneous insulin infusion in patients with diabetes mellitus. Therap. Apher. Dial., 2003, 7, 232.
29. Bolli G., Fanelli C., Periello G., De Feo P.: Nocturnal blood glucose control in type 1 diabetes mellitus. Diabetes Care, 1993, 16, supl. 3, 71
30. Deiss D., Kordonouri O., Heidtmann B. i wsp.: Insulin dosing in children with type 1 diabetes and continuous subcutaneous insulin infusion. ISPAD. J. Pediatr. Endocrinol. Metab., 2003, supl. 4, 926.
31. DiMeglio L.A., Boyd S.R., Pottorff T.M. i wsp.: Preschollers are not miniature adolescents: a comparison of insulin pump doses in two groups of children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2004, 17, 865.
32. Hanas R., Samuelsson A.: Basal and bolus doses in children and adolescents when starting with insulin pump and after at least one year of treatment. ISPAD. J. Pediatr. Endocrinol. Metab., 2003, 16, supl. 4, 925.
33. Hildebrandt P., Birch K.: Subcutaneous insulin infusion: change in basal rate infusion has no immediate effect on insulin absorption rate. Diabetes Care, 1986, 9, 561.
34. Lee S.W., Cao M., Sajid S. i wsp.: The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in type 1 diabetes. Diabetes. Nutr. Metab., 2004, 17, 211.
35. Jones S.M., Quarry J.L., Caldwell-McMillan M. i wsp.: Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabetes Technol. Therap., 2005, 7, 233.
36. Sulli N., Shashaj B.: Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J. Pediatr. Endocrinol. Metab., 2003, 16, 393.